Volume 13, Number 2—February 2007
Dispatch
Characteristics of Staphylococcus aureus Infections, Chicago Pediatric Hospital
Preeti Jaggi*, Suzanne M. Paule†, Lance R. Peterson†, and Tina Q. Tan*
Table 2
Susceptibility data for CA-MRSA isolates from children*
| Susceptibility to antimicrobial agent† | CA-MRSA isolates causing invasive disease, n (%) | CA-MRSA isolates causing local skin/soft tissue infections, n (%) | p value |
|---|---|---|---|
| Resistant to erythromycin | 16/18 (88.9) | 11/18 (61) | NS |
| Apparently susceptible to clindamycin | 18/18 (100) | 18/18 (100) | NS |
| Inducible clindamycin resistance | 3/16 (19) | 0/10 (0) | NS |
| Resistant to ciprofloxacin | 2/18 (11) | 1/18 (6) | NS |
| Resistant to levofloxacin | 1/18 (6) | 1/18 (6) | NS |
| Resistant to tetracycline | 1/18 (5) | 2/18 (11) | NS |
*CA-MRSA, community-associated methicillin-resistant Staphylococcus aureus; NS, not significant.
†In addition to the antimicrobial agents listed, all isolates were susceptible to vancomycin, linezolid, and rifampin.
Page created: June 29, 2010
Page updated: June 29, 2010
Page reviewed: June 29, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.